Mapping The Future: Q&A With Mark Sawicki, Ph.D., On 2025 Trends In Cell And Gene Therapy

The cell and gene therapy (CGT) industry experienced significant advancements in 2024, marked by an expansion in trial diversity and groundbreaking clinical research that is reshaping the landscape of the field. As the CGT sector enters a crucial phase of commercial growth and therapy expansion, Mark Sawicki, Ph.D., CEO of Cryoport Systems, offers his expert insights into the future of the market. He reflects on the transformative developments of the past year and shares his key predictions for 2025, highlighting the evolving trends and challenges that will shape the industry.

Dr. Sawicki also discusses how Cryoport Systems, with its innovative solutions and strategic expertise, is uniquely positioned to support the continued growth and success of cell and gene therapies, furthering the industry's advancements in the years to come.